Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Antibe Therapeutics Inc(Pre-Merger)
ATBPF
Healthcare
Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,...
otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:ATBPF)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
...
Next
(3)
•••
themagicbox
X
View Profile
View Bullboard History
Comment by
themagicbox
on Nov 19, 2022 10:56am
RE:RE:Webinar w $ATE CEO Dan Legault - Mon Nov 21 @ 4:15PM ET
I am looking forward to this. If I had to bet money on it, think Wallace stepped down to focus specifically on IBD. And since this was quiet recent, I wouldnt be surprised if we dont hear an update
...more
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Nov 18, 2022 1:44pm
There is a good story
on the NDVA booard about the time i punked davgro. he is just figuring it out now, thats why he is having another temper tantrum LMFAO
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Comment by
Duster340
on Nov 18, 2022 1:27pm
RE:To be persuasive, we must be believable ....
davgro is none of the above, he is a proven liar he respond directly to my post on the NDVA board, when he said i was on ignore, flat out lie. so that eliminates credible, believable and truthful
...more
(450)
•••
davgro
X
View Profile
View Bullboard History
Post by
davgro
on Nov 18, 2022 12:43pm
To be persuasive, we must be believable ....
This post speaks for itself. https://stockhouse.com/companies/bullboard?symbol=t.byl&postid=35110742 To be persuasive, we must be believable; to be believable, we must be credible; to be
...more
(55)
•••
StockingUp21
X
View Profile
View Bullboard History
Comment by
StockingUp21
on Nov 17, 2022 7:54pm
RE:RE:Webinar w $ATE CEO Dan Legault - Mon Nov 21 @ 4:15PM ET
Mugoo been pumping this ibd update hundred of times but sadly after 20 years they only have enough money for this without a huge dulution.
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Nov 17, 2022 7:00pm
RE:Webinar w $ATE CEO Dan Legault - Mon Nov 21 @ 4:15PM ET
Brings up a good question ... is it Q&A with or without the Q4 IBD update ? If it's without the IBD update, why not wait unitl we get the update, until we get the presentation ... then host a
...more
(37)
•••
bmreed
X
View Profile
View Bullboard History
Post by
bmreed
on Nov 17, 2022 4:00pm
Webinar w $ATE CEO Dan Legault - Mon Nov 21 @ 4:15PM ET
Webinar - Antibe Therapeutics $ATE w/ CEO Dan Legault Mon, November 21 at 4:15pm ET / 1:15pm PT Q&A with Radius Research Register Here - https://us02web.zoom.us/webinar/register
...more
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Nov 17, 2022 2:48pm
If we can hold above 45 cents 😬
for the rest of the year, i guess that will be a win
(29)
•••
nobeard
X
View Profile
View Bullboard History
Comment by
nobeard
on Nov 17, 2022 1:28pm
RE:RE:RE:RE:Buying started ...
Thank you
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Nov 17, 2022 11:52am
Hey everybody davgro is showing his age again haha
(450)
•••
davgro
X
View Profile
View Bullboard History
Comment by
davgro
on Nov 17, 2022 11:40am
RE:RE:RE:Buying started ...
Hey nobeard, I can see from a previous post of yours that you have the Dumpster on ignore so you won't see his response to your question. So here is my answer: On November 16th Joseph
...more
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Nov 17, 2022 11:30am
RE:RE:RE:Buying started .😎.
joe bought at 36.2us which is 48.36cdn as of todays current exchange rate
(29)
•••
nobeard
X
View Profile
View Bullboard History
Comment by
nobeard
on Nov 17, 2022 11:20am
RE:RE:Buying started ...
Would some one be able to shed some light on how Joe bought shares at 0.39 when we haven't been that low?
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Nov 17, 2022 10:53am
Another down day 📉
for the markets ....
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Post by
MrMugsy
on Nov 17, 2022 9:36am
To do list ...
Items still outstanding for 2022 ... 1. IBD update (calendar Q4) 2. Presentation upate (assuming it follows the IBD update) 3. Animal Studies to lead to acute/chronic dosing
...more
Prev
...
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >